Literature DB >> 6652873

Radioimmunoassay of O6-methyldeoxyguanosine in DNA of cells alkylated in vitro and in vivo.

C P Wild, G Smart, R Saffhill, J M Boyle.   

Abstract

Mouse monoclonal and rabbit polyclonal antibodies have been prepared against O6-methylguanosine complexed with bovine serum albumin. In radioimmunoassay 50% inhibition of binding of [3H]O6-methyldeoxyguanosine (O6-MedG) was obtained with 0.3 pmol or 0.16 pmol unlabelled O6-MedG using monoclonal or polyclonal antibodies having affinity constants of 3.0 X 10(9) and 5.9 X 10(9) I mol-1 respectively. Cross-reactivity with normal nucleosides and other adducts was determined. Sensitivity and reproducibility were improved by chromatographic separation using an Aminex A6 column eluted with 10 mM NH4HCO3 buffer which allowed quantitation of one molecule O6-MedG per 10(7) molecules dG in 2 mg calf thymine DNA. Values for O6-MedG from 14 samples of rat liver and kidney DNA analysed by the method described and by radiochromatography on Sephadex G10 were almost identical (correlation coefficient, 0.98). A modified procedure for the purification of 5-25 micrograms DNA from 1-5 X 10(6) fibroblasts applied to polycarbonate filters was used in providing further validation of the RIA system by measuring the persistence of O6-MedG in cell lines of known repair capacity.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6652873     DOI: 10.1093/carcin/4.12.1605

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  15 in total

Review 1.  Estimation of exposure of man to substances reacting covalently with macromolecules.

Authors:  P B Farmer; H G Neumann; D Henschler
Journal:  Arch Toxicol       Date:  1987-06       Impact factor: 5.153

2.  Elevated levels of the pro-carcinogenic adduct, O(6)-methylguanine, in normal DNA from the cancer prone regions of the large bowel.

Authors:  A C Povey; C N Hall; A F Badawi; D P Cooper; P J O'Connor
Journal:  Gut       Date:  2000-09       Impact factor: 23.059

3.  Strand breaks arising from the repair of the 5-bromodeoxyuridine-substituted template and methyl methanesulphonate-induced lesions can explain the formation of sister chromatid exchanges.

Authors:  R Saffhill; C H Ockey
Journal:  Chromosoma       Date:  1985       Impact factor: 4.316

4.  Temporal cell-type-specific mRNA expression of O6-methylguanine-DNA methyltransferases in liver of rats treated with dimethylnitrosamine.

Authors:  S Takahashi; J Hall; R Montesano
Journal:  Am J Pathol       Date:  1996-02       Impact factor: 4.307

5.  Trophoblast glycoprotein recognised by monoclonal antibody 5T4 maps to human chromosome 6q14-q15.

Authors:  J M Boyle; K H Grzeschik; P R Heath; J E Morten; P L Stern
Journal:  Hum Genet       Date:  1990-04       Impact factor: 4.132

6.  Characterisation of monoclonal antibodies which specifically recognise the human erythrocyte glucose transport protein.

Authors:  J M Boyle; A D Whetton; T M Dexter; K Meeran; S A Baldwin
Journal:  EMBO J       Date:  1985-12-01       Impact factor: 11.598

7.  Chemical and biochemical dosimetry of exposure to genotoxic chemicals.

Authors:  G N Wogan; N J Gorelick
Journal:  Environ Health Perspect       Date:  1985-10       Impact factor: 9.031

8.  Quantitation and visualization of alkyl deoxynucleosides in the DNA of mammalian cells by monoclonal antibodies.

Authors:  J Adamkiewicz; G Eberle; N Huh; P Nehls; M F Rajewsky
Journal:  Environ Health Perspect       Date:  1985-10       Impact factor: 9.031

9.  Quantitation of exposure to benzo[a]pyrene with monoclonal antibodies.

Authors:  R M Santella; L L Hsieh; C D Lin; S Viet; I B Weinstein
Journal:  Environ Health Perspect       Date:  1985-10       Impact factor: 9.031

10.  Use of monoclonal and polyclonal antibodies against DNA adducts for the detection of DNA lesions in isolated DNA and in single cells.

Authors:  R A Baan; O B Zaalberg; A M Fichtinger-Schepman; M A Muysken-Schoen; M J Lansbergen; P H Lohman
Journal:  Environ Health Perspect       Date:  1985-10       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.